Zerumbone Shows Promise Against Cervical Cancer by Disrupting IL-10 Immune Signaling
A new study combines computational modeling and cell-based experiments to show that the plant compound zerumbone suppresses IL-10–driven JAK–STAT signaling ...
A new study combines computational modeling and cell-based experiments to show that the plant compound zerumbone suppresses IL-10–driven JAK–STAT signaling ...
A chart review of 1,083 refugee and immigrant patients at a Syracuse academic clinic reveals major gaps in lung, liver, ...
A meta-analysis of 25 studies across 11 countries found that structured interventions roughly double the odds that screen-positive women complete ...
A new editorial in Cancer Causes & Control argues that the most powerful tools against breast, ovarian, cervical, and endometrial ...
New research reveals that the motor protein KIFC1 drives cervical cancer radioresistance by shuttling the splicing factor SRSF3 into the ...
A three-year study of over 23,000 women in Suzhou's Taihu region found a stable 13.20 percent HPV prevalence dominated by ...
Five-year results from the KEYNOTE-826 trial confirm that adding pembrolizumab to first-line chemotherapy delivers durable survival benefit for patients with ...
A cross-sectional study of nearly 20,000 women in Shanxi, China, reports that high-risk HPV infection affects 10.9 percent of those ...
A multi-omics study traces cervical carcinogenesis from normal tissue to invasive cancer and identifies galectin-9-driven immune evasion as a promising ...
A retrospective Turkish study of 144 cervical cancer patients finds that tumor size independently predicts survival within the heterogeneous FIGO ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine